These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
448 related items for PubMed ID: 18408571
21. Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States. Singal AK, Hasanin M, Kaif M, Wiesner R, Kuo YF. Transplantation; 2016 Mar; 100(3):607-12. PubMed ID: 26479282 [Abstract] [Full Text] [Related]
22. The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis. Dutkowski P, Oberkofler CE, Béchir M, Müllhaupt B, Geier A, Raptis DA, Clavien PA. Liver Transpl; 2011 Jun; 17(6):674-84. PubMed ID: 21618688 [Abstract] [Full Text] [Related]
23. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus. Thuluvath PJ, Maheshwari A, Thuluvath NP, Nguyen GC, Segev DL. Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709 [Abstract] [Full Text] [Related]
24. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. Piscaglia F, Camaggi V, Ravaioli M, Grazi GL, Zanello M, Leoni S, Ballardini G, Cavrini G, Pinna AD, Bolondi L. Liver Transpl; 2007 Jun; 13(6):857-66. PubMed ID: 17539006 [Abstract] [Full Text] [Related]
25. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Ioannou GN, Perkins JD, Carithers RL. Gastroenterology; 2008 May; 134(5):1342-51. PubMed ID: 18471511 [Abstract] [Full Text] [Related]
28. MELD may not be the better system for organ allocation in liver transplantation patients in Singapore. Lee YM, Fernandez M, Da Costa M, Lee KH, Sutedja DS, Tai BC, Tan KC, Isaac J, Prabhakaran K, Lim SG. Singapore Med J; 2006 Jul; 47(7):592-4. PubMed ID: 16810430 [Abstract] [Full Text] [Related]
35. Impact of model for end-stage liver disease on patient survival and disease-free survival in patients receiving liver transplantation for hepatocellular carcinoma. Moonka D, Castillo E, Kumer S, Abouljoud M, Divine G, Pelletier S. Transplant Proc; 2009 Nov; 41(1):216-8. PubMed ID: 19249517 [Abstract] [Full Text] [Related]
38. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans. Ahmad J, Downey KK, Akoad M, Cacciarelli TV. Liver Transpl; 2007 Nov; 13(11):1564-9. PubMed ID: 17969210 [Abstract] [Full Text] [Related]